Skip to main content

Table 2 Comparison of baseline data, hematological parameters and coronary angiography data in elevated FBG group and control group

From: Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction

VariablesElevated FBG group (n = 589)Normal FBG group(n = 369)P value
Gender(man)433 (73.5%)303 (82.1%)0.002*
Age62.91 ± 13.0161.72 ± 13.840.185
Height(cm)166.77 ± 7.64166.70 ± 7.200.087
Weight(kg)69.02 ± 12.2068.15 ± 11.730.319
BMI(kg/m2)24.77 ± 3.7024.09 ± 3.710.012*
SBP(mmHg)127.08 ± 23.18125.34 ± 19.140.235
DBP(mmHg)76.89 ± 15.0576.44 ± 13.840.467
Hypertension349 (59.3%)202 (54.7%)0.169
Diabetes242 (41.1%)20 (5.4%)< 0.001*
Previous MI15 (2.5%)7 (1.9%)0.514
Cerebral infarction,86 (14.6%)16 (4.3%)< 0.001*
CKD54 (9.2%)25 (6.8%)0.190
Smoking283 (48.0%)216 (58.5%)0.002*
Killip grade
 I grade367 (62.3%)293 (79.4%)< 0.001*
 II grade103 (17.5%)51 (13.8%)0.133
 III grade9 (1.5%)2 (0.5%)0.163
 IV grade99 (16.8%)34 (9.2%)< 0.001*
TNI P50(P25-P75)(ng/ml)17 (3.98–25)11 (2.3–25)0.002*
Myo P50(P25-P75) (ng/ml)500 (219.75–900)500 (206.25–900)0.016*
CK-MB P50(P25-P75)(ng/ml)80 (36.45–297)80 (37.5–246.5)0.260
BNP P50(P25-P75) (pg/ml)173 (49.75–587.5)112 (41.45–347.5)0.001*
WBC (*10^9/L)12.29 ± 4.4510.47 ± 2.94< 0.001*
Hb (g/L)134.5 ± 23.11135.99 ± 20.710.066
PLT (*10^9/L)209.87 (160.3–268.3)201.7 (170.4–259.2)0.051
RBG(mmol/L)11.25 (9.3–16.5)7.22 (6.8–10.0)< 0.001*
ALT P50(P25-P75)IU/L)48 (33–79)39 (29–59)< 0.001*
AST P50(P25-P75) (IU/L)145 (60–219)171 (89–309)< 0.001*
Scr P50(P25-P75) (μmol/L)81 (67–98)80 (72–91)0.862
eGFR P50(P25-P75)
(ml/min/1.73m2)
80.9 (62.22–97.88)81.7 (69.2–96.2)0.704
UA(μmol/L)376.41 (280.3–390.3.2)365.35 (249.5–378.4)0.152
FBG(mmoL/L)9.79 ± 2.675.22 ± 0.52< 0.001*
TG(mmoL/L)1.83 (1.28–2.56)1.64 (0.89–2.06)0.051
TC(mmoL/L)4.46 (4.13–5.84)4.42 (4.02–5.73)0.667
HDL-c(mmoL/L)1.12 (0.83–1.46)1.07 (0.95–1.47)0.046*
LDL-c(mmoL/L)2.77 (2.19–3.07)2.80 (2.26–3.26)0.682
LVEF (%)0.53 ± 0.380.68 ± 0.34< 0.001*
Aspirin581 (98.6%)364 (98.6%)0.997
Clopidogrel61 (10.4%)55 (14.9%)0.028*
Ticagrelor528 (89.6%)314 (85.1%)0.028*
ACEI/ARB277 (47.0%)205 (55.6%)0.01*
β-blocker494 (83.9%)300 (81.3%)0.304
Statin586 (99.5%)367 (99.5%)0.946
CCB30 (5.1%)30 (8.1%)0.059
Furosemide174 (29.5%)75 (20.3%)0.002*
Antisterone172 (29.2%)77 (20.9%)0.004*
IABP51 (8.7%)12 (3.3%)0.001*
CABG10 (17.1%)3 (0.8%)0.249
Coronary lesions
 Single vessel lesion101 (29.0%)135 (36.6%)< 0.001*
 Double vessel lesions171(%)115 (31.2%)0.483
 Triple vessel lesions284 (48.2%)152 (41.2%)0.034*
Number of stents
 Single stent340 (57.7%)242 (65.6%)0.015*
 Two or more stents124 (21.1%)53 (14.4%)0.009*
 Left main lesion75 (12.7%)24 (6.5%)0.002*